PortfoliosLab logoPortfoliosLab logo
TBUX vs. RPRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TBUX vs. RPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Ultra Short-Term Bond ETF (TBUX) and Royalty Pharma plc (RPRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TBUX achieves a 1.65% return, which is significantly lower than RPRX's 43.64% return.


TBUX

1D
-0.04%
1M
0.41%
YTD
1.65%
6M
2.09%
1Y
4.77%
3Y*
5.85%
5Y*
10Y*

RPRX

1D
1.78%
1M
9.99%
YTD
43.64%
6M
40.16%
1Y
68.67%
3Y*
21.21%
5Y*
6.45%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TBUX vs. RPRX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TBUX
T. Rowe Price Ultra Short-Term Bond ETF
1.65%5.37%6.38%6.39%-0.13%-0.22%
RPRX
Royalty Pharma plc
43.64%55.29%-6.36%-27.08%0.99%9.08%

Correlation

The correlation between TBUX and RPRX is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Sep 30, 2021

0.04

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TBUX vs. RPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TBUX
TBUX Risk / Return Rank: 9999
Overall Rank
TBUX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
TBUX Sortino Ratio Rank: 9999
Sortino Ratio Rank
TBUX Omega Ratio Rank: 9999
Omega Ratio Rank
TBUX Calmar Ratio Rank: 9999
Calmar Ratio Rank
TBUX Martin Ratio Rank: 9999
Martin Ratio Rank

RPRX
RPRX Risk / Return Rank: 9595
Overall Rank
RPRX Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
RPRX Sortino Ratio Rank: 9494
Sortino Ratio Rank
RPRX Omega Ratio Rank: 9494
Omega Ratio Rank
RPRX Calmar Ratio Rank: 9797
Calmar Ratio Rank
RPRX Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TBUX vs. RPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Ultra Short-Term Bond ETF (TBUX) and Royalty Pharma plc (RPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TBUXRPRXDifference
Sharpe ratioReturn per unit of total volatility

+3.96

Sortino ratioReturn per unit of downside risk

+10.41

Omega ratioGain probability vs. loss probability

3.08

1.53

+1.56

Calmar ratioReturn relative to maximum drawdown

39.71

9.35

+30.36

Martin ratioReturn relative to average drawdown

170.19

23.50

+146.69

TBUX vs. RPRX - Sharpe Ratio Comparison

The current TBUX Sharpe Ratio is 7.13, which is higher than the RPRX Sharpe Ratio of 3.17. The chart below compares the historical Sharpe Ratios of TBUX and RPRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TBUXRPRXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

7.13

3.17

+3.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

3.89

0.22

+3.67

Drawdowns

TBUX vs. RPRX - Drawdown Comparison

The maximum TBUX drawdown since its inception was -1.79%, smaller than the maximum RPRX drawdown of -49.68%. Use the drawdown chart below to compare losses from any high point for TBUX and RPRX.


Loading charts...

Drawdown Indicators


TBUXRPRXDifference

Max Drawdown

Largest peak-to-trough decline

-1.79%

-49.68%

+47.89%

Max Drawdown (1Y)

Largest decline over 1 year

-0.12%

-7.38%

+7.26%

Max Drawdown (3Y)

Largest decline over 3 years

-0.33%

-26.46%

+26.13%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

Current Drawdown

Current decline from peak

-0.04%

-1.42%

+1.38%

Average Drawdown

Average peak-to-trough decline

-0.28%

-26.44%

+26.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.03%

2.93%

-2.90%

Volatility

TBUX vs. RPRX - Volatility Comparison

The current volatility for T. Rowe Price Ultra Short-Term Bond ETF (TBUX) is 0.19%, while Royalty Pharma plc (RPRX) has a volatility of 6.08%. This indicates that TBUX experiences smaller price fluctuations and is considered to be less risky than RPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TBUXRPRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.19%

6.08%

-5.89%

Volatility (6M)

Calculated over the trailing 6-month period

0.43%

14.04%

-13.61%

Volatility (1Y)

Calculated over the trailing 1-year period

0.67%

21.75%

-21.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

1.07%

23.92%

-22.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1.07%

26.87%

-25.80%

Dividends

TBUX vs. RPRX - Dividend Comparison

TBUX's dividend yield for the trailing twelve months is around 4.48%, more than RPRX's 1.66% yield.


PositionTTM202520242023202220212020
RPRX
Royalty Pharma plc
1.66%2.28%3.29%2.85%1.92%1.71%0.60%
TBUX
T. Rowe Price Ultra Short-Term Bond ETF
4.48%4.67%5.39%4.66%2.58%0.27%0.00%

Frequently Asked Questions


TBUX and RPRX have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RPRX has higher volatility (6.08%) compared to TBUX (0.19%). In terms of maximum drawdown, TBUX dropped -1.79% vs RPRX's -49.68%.

TBUX currently has the higher Sharpe Ratio (7.13 vs 3.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TBUX and RPRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer